Amy H. Farabaugh, PhD
- 2Articles
- 7.5KReads1
- 2003–2009Active
- 14Collaborators
- 77Citations2
About
Amy H. Farabaugh, PhD, has published research focused on major depressive disorder (MDD), including clinical trials of ethyl-eicosapentaenoate and investigations into psychiatric comorbidity as a predictor of treatment response with nortriptyline in treatment-resistant MDD. Her work, published between 2003 and 2009, appears in Psychiatrist.com journals. Frequent collaborators include Andrew A. Nierenberg, Jonathan E. Alpert, Maurizio Fava, A. Monica Agoston, and Christina M. Dording.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
